MedTrace Logo

Safety and Efficacy Study of the Treatment of Kidney Infections With Short Course Levofloxacin

NCT00239161 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2005-10-14

No results posted yet for this study

Summary

The purpose of the study is to compare the safety and effectiveness of the antibiotic levofloxacin by administering a higher dose of levofloxacin using a shorter course of therapy to treat patients with infections of their kidney.

Conditions

  • Acute Uncomplicated Pyelonephritis

Interventions

DRUG

Levofloxacin

Sponsors & Collaborators

  • Ortho-McNeil Pharmaceutical

    collaborator INDUSTRY

  • Janssen-Ortho Inc., Canada

    collaborator INDUSTRY

  • PriCara, Unit of Ortho-McNeil, Inc.

    collaborator INDUSTRY

  • University of Manitoba

    lead OTHER

Principal Investigators

  • Lindsay E Nicolle, MD, FRCPC · University of Manitoba

  • Godfrey KM Harding, MD, FRCPC · University of Manitoba

  • George G Zhanel, PhD, FCCP · University of Manitoba

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-09-30
Completion
2005-07-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00239161 on ClinicalTrials.gov